- Home
- NUS vs GUG Comparison
NUS vs GUG Comparison
Compare NUS & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- GUG
- Stock Information
- Founded
- NUS 1984
- GUG 2021
- Country
- NUS United States
- GUG United States
- Employees
- NUS N/A
- GUG N/A
- Industry
- NUS Other Pharmaceuticals
- GUG Trusts Except Educational Religious and Charitable
- Sector
- NUS Health Care
- GUG Finance
- Exchange
- NUS Nasdaq
- GUG Nasdaq
- Market Cap
- NUS 603.4M
- GUG 524.4M
- IPO Year
- NUS 1996
- GUG N/A
- Fundamental
- Price
- NUS $11.22
- GUG $16.06
- Analyst Decision
- NUS Hold
- GUG
- Analyst Count
- NUS 2
- GUG 0
- Target Price
- NUS $6.88
- GUG N/A
- AVG Volume (30 Days)
- NUS 640.2K
- GUG 108.9K
- Earning Date
- NUS 11-06-2025
- GUG 01-01-0001
- Dividend Yield
- NUS 2.15%
- GUG 9.67%
- EPS Growth
- NUS N/A
- GUG N/A
- EPS
- NUS 2.03
- GUG N/A
- Revenue
- NUS $1,626,325,000.00
- GUG N/A
- Revenue This Year
- NUS N/A
- GUG N/A
- Revenue Next Year
- NUS $0.98
- GUG N/A
- P/E Ratio
- NUS $5.50
- GUG N/A
- Revenue Growth
- NUS N/A
- GUG N/A
- 52 Week Low
- NUS $5.32
- GUG $12.71
- 52 Week High
- NUS $14.62
- GUG $15.06
- Technical
- Relative Strength Index (RSI)
- NUS 44.44
- GUG N/A
- Support Level
- NUS $10.93
- GUG N/A
- Resistance Level
- NUS $12.59
- GUG N/A
- Average True Range (ATR)
- NUS 0.67
- GUG 0.00
- MACD
- NUS -0.20
- GUG 0.00
- Stochastic Oscillator
- NUS 7.05
- GUG 0.00
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.